Dr. Ryszard Nosalski is an Honorary Research Fellow at the School of Cardiovascular & Metabolic Health, University of Glasgow. His research focuses on understanding immune mechanisms underlying hypertension, vascular inflammation, and cardiovascular disease progression. He collaborates extensively with the British Heart Foundation (BHF) Cardiovascular Research Centre. Key research interests include vascular inflammation pathways, T-cell-mediated fibrosis in hypertension, and therapeutic targeting of oxidative stress (e.g., NOX enzymes). His work bridges basic science and translational medicine, addressing clinical challenges such as chemotherapy-induced hypertension and periodontitis-hypertension associations. Recipient of a 2022-2023 grant from Tenovus Scotland for studying the IL-15/IL-15Ra axis in cardiac damage during hypertension. Published over 20 peer-reviewed articles in high-impact journals like Nature Reviews Cardiology , Hypertension , and Circulation Research . His recent work highlights novel therapeutic strategies for vascular inflammation and demonstrates how immune responses contribute to hypertension pathophysiology. Ongoing projects investigate neuroimmune interfaces in atherosclerosis and the role of microRNAs in fibrosis.
Sonia Navas-Martin is a Professor in the Department of Microbiology & Immunology at Drexel University College of Medicine. She holds a PhD from Universidad Autónoma de Madrid (1997). Her research focuses on innate immunity mechanisms during viral infections and neurodegenerative diseases, with emphasis on CNS pathologies and cellular senescence. Education: PhD in Microbiology & Immunology, Universidad Autónoma de Madrid (1997) Research Interests: Dr. Navas-Martin investigates how innate immune pathways contribute to immunopathology in viral infections (e.g., coronaviruses), neuroinflammation, and neurodegenerative diseases like Alzheimer’s. Her work combines molecular biology, immunology, and animal models to identify therapeutic targets. Key areas include: Microglial responses to viral pathogens Role of non-coding RNAs (e.g., miRNAs) in immune regulation Cellular senescence in HIV-associated neurocognitive disorders Cross-talk between TLR signaling and viral replication Publications: Her recent work includes studies on SARS-CoV-2 antiviral strategies, microglial antiviral mechanisms, and HIV-HCV co-infection dynamics. The articles reflect a focus on innate immunity modulation, viral pathogenesis, and translational therapies. Awards: Curator, American Society for Microbiology’s COVID-19 Research Registry Grants & Mentorship: She oversees an NIH-funded neuroimmunology graduate position and mentors students in scientific excellence. Her lab is known for collaborative, open research environments fostering innovation. Labs & Teams: Active in the Institute for Molecular Medicine & Infectious Disease at Drexel, collaborating on coronavirus immunology and SARS-CoV-2 therapeutic development. Her research integrates virology, immunology, and neurobiology to address critical gaps in understanding viral CNS pathogenesis.
Gabriele Romano, PhD, is an Assistant Professor in the Department of Pharmacology & Physiology at Drexel University College of Medicine. His research focuses on cancer drug resistance mechanisms, leveraging mouse modeling, functional genomics, and computational biology. He leads the Romano Lab, which explores tumor-stroma interactions in minimal residual disease, tumor suppressor roles in therapy resistance, and HIV-cancer comorbidity. Education: PhD - Molecular and Translational Medicine, University of Milan, Bicocca (2015) MS - Medical Biotechnology, University of Milan, Bicocca (2012) BS - Biotechnology, University of Milan, Bicocca (2010) Research Interests: Cancer drug resistance mechanisms Immune evasion and tumor microenvironment Therapeutic strategies for HIV-associated cancers Functional genomics and nanoparticle delivery His work emphasizes developing novel therapies targeting residual tumor cells and improving outcomes for immunocompromised cancer patients. Key Awards: 2023 WW Smith Trust nominee (Cancer Research) 2022 Pew Biomedical Scholars competition nominee 2019 Maryanne Rosenstein Family Fellowship in Cancer Research Grants & Collaborations: Recipient of multiple institutional and foundation grants Collaborations with global institutions on translational projects Focus on mouse models, CRISPR screens, and bioinformatics Labs & Teams: Romano Lab at Drexel University Partnerships with MD Anderson Cancer Center and The Jackson Lab
Javier Caceres is a Professor of RNA and Gene Expression holding a Personal Chair at the MRC Human Genetics Unit within the Institute of Genetics and Molecular Medicine (IGMM) at the University of Edinburgh. He has served as Head of the Genome Regulation Section since 2015, leading research on RNA-mediated genetic mechanisms. His educational background includes a Ph.D. in Molecular Biology (1989) and an MSc. in Biology (1985), both obtained from the University of Buenos Aires. These degrees established his foundation in molecular genetics before his postdoctoral work at Cold Spring Harbor Laboratory and the University of Wisconsin-Madison. Dr. Caceres' research centers on RNA biology with emphasis on post-transcriptional gene regulation. His work investigates alternative splicing mechanisms, nonsense-mediated decay pathways, microRNA functions, and RNA-protein interactions. These studies provide critical insights into genetic disorders and potential therapeutic targets, particularly in splicing-related diseases. His experimental approaches combine biochemical, genomic, and cellular techniques to dissect RNA regulatory networks. Analysis of his publication record reveals consistent focus on RNA processing mechanisms across three decades. His work demonstrates evolving technical sophistication from foundational splicing studies to contemporary systems-level analyses of RNA regulation, with sustained contributions to understanding how RNA dysregulation causes human disease. Key themes include RNA-binding proteins, mRNP dynamics, and quality control pathways. His major scientific recognitions include: Election as Fellow of the Royal Society of Edinburgh (FRSE) in 2011 Award of the Wellcome Trust Senior Investigator Award in 2011 Membership in the European Molecular Biology Organization (EMBO) since 2008 Dr. Caceres actively shapes scientific discourse through editorial leadership as Associate Editor of RNA (since 2011) and service on editorial boards of EMBO Journal and Nucleic Acids Research. He has evaluated research proposals for major funding bodies including the European Research Council (ERC Starting Grants panel), German Research Foundation (DFG), and Swiss National Foundation, focusing on molecular biology and RNA research initiatives. He directs the Genome Regulation Section at the MRC Human Genetics Unit, where his team employs cutting-edge methodologies to investigate RNA-mediated gene regulation mechanisms and their roles in human disease pathogenesis.
John Iacomini is a Professor at Tufts University School of Medicine , affiliated with the Department of Immunology and cross-appointed in Genetics, Molecular and Cellular Biology, and other biomedical programs. He has taught courses like Intro to Immunology and Advanced Cellular Immunology since 2011. Doctor of Philosophy , Tufts University (1991) Bachelor of Science , Syracuse University (1986) His research focuses on adaptive immune responses , immunological tolerance , and the role of microRNAs in T cell activation and tissue injury responses . Recent work explores how hyperlipidemia and dietary factors influence organ transplant rejection and immune regulation. His publications since 2015 highlight studies on Treg dysfunction , Th17 cell pathogenicity , microRNA-mRNA interactions in nephrotoxicity, and hormonal modulation of T cells. These studies often intersect transplant immunology and metabolic-immune crosstalk . Scientific Awards NIH Grant: Post-transcriptional regulation of gene expression by microRNAs (2021-2026) NIH Grant: Microbial disruption of dendritic cell function (2018-2023) NIH Grant: Hyperlipidemia effects on immune memory (2018-2020) NIH Grant: Diet-induced transplant rejection (2015-2020) American Heart Association Grant: Hyperlipidemia in cardiac rejection (2014) As a mentor, he has advised graduate students like Christopher Benway and contributed to training programs. His laboratory remains active in uncovering mechanisms of immune tolerance , microRNA regulation , and metabolic influences on transplant outcomes .
Dr. Peixin Yang is the Christopher R. Harman, MD Endowed Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of Maryland School of Medicine. He serves as Professor with tenure in the Department of Obstetrics, Gynecology and Reproductive Sciences and holds a secondary appointment in the Department of Biochemistry & Molecular Biology. Dr. Yang is the founding director of the Center for Birth Defect Research at the University of Maryland School of Medicine and leads multiple NIH-funded research projects totaling millions of dollars. Dr. Yang's educational background includes: B.S. in Animal Science from Zhejiang Agricultural University (1986-1990) M.S. in Animal Reproductive Sciences from Nanjing Agricultural University (1990-1993) Ph.D. in Biophysics from Tokyo University of Agriculture & Technology and Zhejiang University (1994-1999) Postdoctoral Research Associate at University of Nebraska Medical Center (1999-2002) BIRCWH scholar (NIH K12) at University of Maryland Baltimore (2008-2009) Dr. Yang has built an extensive research program focused on diabetic embryopathy, particularly examining how maternal diabetes induces neural tube defects (NTDs), congenital heart defects (CHDs), and kidney defects. His laboratory was the first to establish a mouse model of diabetic embryopathy and reveal the causal role of JNK1/2 in neural tube defects. He has made significant contributions to understanding the molecular mechanisms of cellular stress, endoplasmic reticulum stress, and autophagy in neural tube defect formation. Dr. Yang also investigates the effects of maternal obesity on placental function and has established the Maryland Maternal Health Research Center of Excellence. His recent work has expanded to include studies on SARS-CoV-2 infection in pregnancy and connections between insulin resistance signaling and Alzheimer's disease. Analysis of Dr. Yang's recent publications reveals a strong focus on the molecular mechanisms of diabetic embryopathy, with particular emphasis on epigenetic regulation, cellular stress signaling pathways, and placental function. His work consistently bridges basic science with clinical applications, developing potential therapeutic approaches for preventing birth defects. A significant portion of his recent research examines the intersection of maternal metabolic conditions (diabetes and obesity) with fetal development, while also expanding into novel areas like viral infections in pregnancy and connections to neurodegenerative diseases. Dr. Yang's notable scientific achievements include: The F. Clarke Fraser New Investigator Award from the Teratology Society (2013) BIRCWH scholar (NIH K12) (2008-2009) The Lalor foundation postdoctoral Fellowship (2002-2003) Dr. Yang currently directs a multi-million dollar NIH-funded research group with multiple active R01 grants. His current projects investigate the intersection of mTOR/p70S6K1 signaling and HIPPO-Yap tissue organizer in neurulation, heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy, hyperglycemia-induced cardiac progenitor dysfunction, and epitranscriptomic alterations in diabetic embryopathy. He has developed a robust research program in maternal diabetes-induced heart defects, which was previously an understudied area. Dr. Yang is also leading efforts to establish the Maryland Maternal Health Research Center of Excellence, focusing on the adverse effects of obesity, placental accreta spectrum, and opioid use disorder. As the founding director of the Center for Birth Defect Research at the University of Maryland School of Medicine, Dr. Yang leads a multidisciplinary team of translational and clinical scientists. His laboratory has made original contributions to understanding the molecular mechanisms underlying maternal diabetes-induced structural birth defects. The team employs genetically modified mouse models, whole-embryo culture systems, and human placental studies to investigate the effects of metabolic conditions on fetal development. Dr. Yang's group has been instrumental in developing natural compounds as potential preventatives for diabetic embryopathy, including trehalose, epigallocatechin-3-gallate, and curcumin.
Professor Philip Taylor is a Professor of Translational Immunology in the Division of Infection and Immunity at Cardiff University's School of Medicine. He serves as PGR Lead for the Systems Immunity Research Institute and is a UK Dementia Research Institute Professor. His research focuses on the innate immune system, particularly macrophages, myeloid cell surface receptors, and the complement system. His educational background includes a PhD in Molecular Genetics from Imperial College London (1998) and a BSc in Human Genetics from University College London (1994). His career progression shows a strong trajectory in immunology research, with positions at Oxford University before joining Cardiff University. Professor Taylor's research interests center on macrophage biology, particularly their origins, development, renewal, and transcriptional control of cellular activation. More recently, he has developed a significant focus on microglia in dementia, especially Alzheimer's disease. He also has interests in developing technologies that promote the 3Rs (Replacement, Reduction, Refinement) in animal research while maintaining scientific excellence. His work heavily involves experimental murine models of disease and immunity with the ultimate goal of elucidating novel mechanisms to manipulate macrophage activity for beneficial outcomes in disease. His recent publications demonstrate a strong trend toward understanding the role of the immune system in neurodegenerative diseases, particularly Alzheimer's, while maintaining his foundational work on macrophage biology and pathogen recognition. The research spans multiple disciplines including immunology, neuroscience, cell biology, and genetics, with strong translational potential. Recipient of a Wellcome Trust Investigator Award (2016-2021) Recipient of a Medical Research Council Senior Fellowship (2007-2014) Awarded Research Lecturer status, Oxford University (2006) Recipient of a Wellcome Trust Research Career Development Fellowship (2003-2007) Awarded RSII status, Oxford University (2002) Recipient of Medical Research Council PhD studentship (1994) Professor Taylor leads the Myeloid Cell Biology Group at Cardiff University, which investigates macrophage biology in homeostasis and disease, as well as the role of microglia in dementia. His current grant funding includes an MRC UK Dementia Research Institute Programme Grant (2017-2023) worth £1.7M and a Wellcome Trust Investigator Award (2016-2021) worth £1.41M. His research group is actively involved in understanding how genes implicated in Alzheimer's disease impact microglial function, with the aim of inspiring novel therapeutic approaches. The Myeloid Cell Biology Group is investigating professional phagocytes (macrophages, dendritic cells, and neutrophils) and their diverse roles in development, host defense, inflammation, wound healing, and immune surveillance. The group focuses on fundamental aspects of phagocyte biology, including pathogen recognition receptors, downstream signaling, and cellular activation events, with the goal of manipulating cell behavior for therapeutic benefit.
Reyad Elbarbary, PhD is an Associate Professor in both the Department of Orthopaedics and Rehabilitation and the Department of Molecular and Precision Medicine . He is affiliated with the Center for Cannabis and Natural Product Pharmaceuticals (CCNPP) , focusing on cannabis-based therapeutics and bone regeneration. His research spans Molecular Biology , Genetics , and Immunology , with a particular emphasis on MicroRNA , Osteoarthritis , and Bone Fracture Healing . Recent studies explore Cannabidiol and Cannabigerol for pain management and healing promotion in mice, alongside immune response defects in obesity-related fractures. Key publications include work on alternative polyadenylation in Bone Research and musculoskeletal methodologies in Journal of Visualized Experiments . His National Institute of Diabetes and Digestive and Kidney Diseases grant (2019–2024) investigates microRNA homeostasis in bone repair.
Anne Marie Jukic, PhD, MSPH serves as an Adjunct Assistant Professor in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. Her research focuses on perinatal epidemiology with emphasis on the pre-conception period, pregnancy outcomes, and child health. Dr. Jukic's research interests include: Early pregnancy events, particularly implantation and placental development Vitamin D's role in reproductive health and fertility Environmental exposures (phthalates and phenols) and their impact on pregnancy Menstrual cycle function as a vital sign for reproductive health Physical activity during pregnancy and pregnancy outcomes Her publications reveal strong trends in digital epidemiology, vitamin D research, and environmental impacts on reproductive health. Recent work leverages large digital cohorts to investigate menstrual patterns, PCOS prediction, and androgen excess across the lifespan. She maintains active collaborations with Norwegian research teams studying placental development and childhood neurodevelopment. Scientific recognition includes: Rising Star Award (2016) from Society for Pediatric and Perinatal Epidemiologic Research Young Investigator Award (2016) from Vitamin D Workshop NIEHS Paper of the Month (2015) Poster Award (2015) from Society for Epidemiologic Research Student Travel Award (2012) from Society for Epidemiologic Research Dr. Jukic directs research within the Yale Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE), investigating how environmental, genetic, and clinical factors impact pregnancy and childhood health. Her current projects include studies on ambient air pollution and miscarriage, vitamin D and cycle regularity, and microRNA in early placental development.
Prof. Dr. Sven-Erik Behrens serves as a Professor in the Department of Microbial Biotechnology at the Faculty of Natural Sciences I of Martin Luther University Halle-Wittenberg. He is affiliated with the Protein Research Center 'Charles Tanford' and maintains an active research program focused on RNA biology, molecular virology, and biotechnological applications. His primary research interests encompass RNA-based plant protection strategies, viral replication mechanisms (particularly for flaviviruses and plant viruses), and innovative vaccine development using Kluyveromyces lactis yeast expression systems. Behrens' work investigates fundamental RNA-protein interactions, RNA chaperone activities, and the molecular basis of antiviral defense mechanisms in plants. His laboratory explores how RNA accessibility influences viral replication and how this knowledge can be harnessed for developing novel RNA-based antiviral strategies. Analysis of his recent publications (2021-2025) reveals a clear research trajectory focused on identifying accessible RNA sites for targeted antiviral applications, optimizing yeast-based vaccine platforms for both plant and animal pathogens, and investigating the role of non-coding RNAs in plant development and stress responses. His work spans multiple disciplines including plant virology, medical virology, and microbial biotechnology, demonstrating translational research from basic molecular mechanisms to practical applications. Prof. Behrens leads research in the Department of Microbial Biotechnology, collaborating with various groups working on plant-pathogen interactions and vaccine development. His laboratory employs advanced techniques including RNA structure probing, fluorescence-based assays for RNA chaperone activity, and plant in vitro systems for studying viral replication. The research demonstrates significant potential for developing novel approaches to combat viral diseases in both agricultural and medical contexts.
Dr. D. Marshall Porterfield is a Professor of Agricultural & Biological Engineering at Purdue University, specializing in biosensors, bio-nanotechnology, and space biology. His research focuses on developing technologies for bioregenerative life support systems and nutrient delivery in microgravity environments. He served as NASA's Division Director for Space Life and Physical Sciences (2012-2016), pioneering initiatives like geneLAB and materialsLAB to advance space research utilization. His work bridges engineering and biology, with applications in space exploration and terrestrial challenges. Porterfield holds leadership roles in organizations like the American Society for Gravitational and Space Research and the Institute for Biological Engineering. He has authored over 100 peer-reviewed papers and holds patents in biosensor technology. Awards include the Halstead Investigator Award and election to the AIMBE College of Fellows. His research portfolio includes lab-on-a-chip devices, biomimetic sensors, and gravitational physiology studies, with recent emphasis on lunar agriculture and space radiation mitigation. His articles highlight advancements in space microbiology, extraterrestrial crop systems, and molecular responses to spaceflight. Key themes include optimizing oxygen delivery for hydroponics, detecting cancer biomarkers via microtest tech, and understanding aging in space environments. Porterfield collaborates across disciplines, leveraging Purdue's facilities like the Birck Nanotechnology Center and Discovery Park for interdisciplinary innovation.
Dr. Shaojun Du is a Professor in the Department of Biochemistry and Molecular Biology at the University of Maryland School of Medicine and a faculty member at the Institute of Marine and Environmental Technology, University of Maryland. His research focuses on genetic and epigenetic mechanisms regulating muscle development, growth, and repair using zebrafish models. Education: PhD in Biochemistry and Molecular Biology (University of Toronto, 1993), Postdoctoral Fellowship in Genetics (Howard Hughes Medical Institute, University of Washington, 1993–1997) Dr. Du’s work explores the roles of molecular chaperones (e.g., Hsp90α1), histone modifiers (e.g., SmyD1), and fusogenic proteins (Myomaker/Myomixer) in myofibril assembly, sarcomere organization, and myoblast fusion. His lab employs Tol2 transposon, TALEN, and CRISPR technologies to generate transgenic and mutant zebrafish models. The scientific awards section is currently empty, but his research has been funded by the NIH (Grant 1R01AR072703-01A1, 2018–2025). His publications highlight breakthroughs in muscle cell identity specification via Hedgehog signaling and the critical role of post-translational modifications in protein stability. Dr. Du’s lab has developed over 40 zebrafish models to study muscle structural proteins, transcription factors, and microRNA networks, contributing to understanding neuromuscular diseases and advancing aquaculture applications.
Dr. Angela Maria Gonella-Diaza is an Assistant Professor in Beef Cattle Reproduction at the University of Florida's North Florida Research and Education Center. Born in Colombia, her early exposure to agricultural production shaped her career in veterinary science and reproductive physiology. She earned her DVM from the National University of Colombia, followed by a Master's in Reproductive Physiology and a Ph.D. at the University of São Paulo, Brazil. Her postdoctoral research focused on molecular patterns of reproductive tract receptivity in beef cows. Dr. Gonella-Diaza's work emphasizes improving reproductive efficiency in Bos indicus breeds through molecular, metabolomic, and genetic approaches. Her research interests include heat stress mitigation strategies, embryo transfer optimization, and the role of metabolomics in bovine reproduction. She has developed protocols for estrus synchronization and pregnancy diagnostics, contributing to practical advancements in beef cattle management. Key themes in her work include understanding how environmental factors like temperature and dietary supplements influence reproductive outcomes and offspring health. Dr. Gonella-Diaza has published extensively on topics such as conceptus survival mechanisms, maternal-offspring metabolic interactions, and the application of microRNA profiling to predict placental phenotypes. Her research bridges fundamental biology with applied agricultural solutions, aiming to enhance livestock productivity and sustainability in subtropical climates.
Tian Hong is an Associate Professor at the Department of Biological Sciences, The University of Texas at Dallas , with a joint appointment as Research Associate Professor at the Department of Biochemistry & Cellular and Molecular Biology, The University of Tennessee, Knoxville . His research focuses on systems biology, bioinformatics, cancer biology, and mathematical biology , particularly the plasticity and heterogeneity of epithelial and immune cells during development and cancer progression . He develops computational and mathematical models for gene regulatory networks, pattern formation, and dynamical systems. Education : PhD in Genetics, Bioinformatics and Computational Biology from Virginia Tech; MS in Bioinformatics from Nanyang Technological University, Singapore; BS in Biological Sciences from Nanyang Technological University, Singapore. Previous Appointments : Associate Professor (2023–2024) and Assistant Professor (2017–2023) at The University of Tennessee, Knoxville. His recent publications explore noncoding RNA-driven oscillations , Turing pattern formation without feedback , and epithelial-mesenchymal transitions using single-cell transcriptomics and mathematical modeling . He has received the Professional Promise in Research and Creative Achievement Award (2024) and the Transdisciplinary Team Science Fellow (2009). His work is funded by NIH grants including R35GM149531 (PI) and R01GM140462 (completed PI). Dr. Hong advises PhD and Master’s students and collaborates with researchers at the Center for Systems Biology, UT Dallas . His lab ( link ) actively seeks undergraduate, graduate, and postdoctoral researchers interested in interdisciplinary computational biology .
Xiaonan ZHANG is an Associate Professor in the Faculty of Science and Technology at the University of Canberra, leading the Hepatitis B Virus (HBV) Group within the Centre for Research into Therapeutic Solutions. He holds a PhD from Fudan University (2012) and previously worked at the Shanghai Public Health Clinical Centre until 2021. His research focuses on HBV molecular pathogenesis, therapeutic vaccine development, and next-generation sequencing applications in viral infections. His work has advanced understanding of HBV’s clinical outcomes, including the discovery of Capsid-Antibody-Complexes (CACs) and their role in pathogenesis. Collaborations span institutions like the Peter Doherty Institute, University of Queensland, and international partners such as Fudan University and University of Duisburg-Essen. Key projects include: Development of therapeutic mRNA vaccines for chronic HBV Clinical evaluation of CAC assays in HBV/HIV co-infections Metagenomic sequencing for pathogen identification Research interests emphasize translational medicine, with contributions to H7N9 influenza and SARS-CoV-2 studies during the pandemic. His team pioneered real-world analyses of viral and host factors in COVID-19 outcomes. Current focus includes liver-resident immune cell dynamics and novel diagnostic assays for HBV nucleic acids. Publications highlight innovations in HBV cccDNA tracking, immune complex mechanisms, and exosome-mediated signaling. No scientific awards were explicitly listed in the provided texts. Xiaonan actively collaborates on grants and supervises PhD students, advancing interdisciplinary approaches to viral diseases.
